Username Password
S&P 500: 1,349.74 Change: +0.07%

ATRICURE INC (ATRC)

Overview
Price 11.24
Price Change Today 0.00 (0.00%)
P&P rating Rating: 5
Zacks Rank 3 - HOLD
Open Price $0.00
Previous Close $11.24
Daily Range $0.00 - $0.00
52-Week Range $8.54 - $14.84
Volume 0
chart
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Other Resources for ATRC
zacks.com
Commentary
No Commentary Found for This Ticker.
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
 
Brokerage Analyst Recommendations
7 Brokerage Firms Covering ATRC
 
   
Strong Buy
5
Buy
1
Hold
1
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 1.39
 
ATRC Ratings:BUY  SELL  HOLD
ATRC Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

6 Buy
0 Sell
 
Top Buy Analysis
BUY: ATRC Rating: 5
Company: ATRICURE INC.
Points: -3.92
Start Price: $11.22
Start Date: 01/12/2012 1:16 PM
Porscheman
Porscheman
P&P Score: 97.98
Recs:
Merger candidate.

Comments: 0 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
PaulShark
1.31 12/28/10 Hypertension Diagnostics Inc. 0
Zacks_Analysts
0.00 06/16/10 AtriCure's Portfolio Strengthened - Analyst Blog 0
Zacks_Analysts
0.00 07/16/09 AtriCure Receives Copy of "Whistleblower" Suit - Analyst Blog 0
Commentary
BUY: ATRICURE INC. (ATRC) Rating: 5
Start Price: $11.22
Points: -3.92
Created: 01/12/2012
Merger candidate.

Comments: 0 | Comment

Recs:
 
BUY: ATRICURE INC. (ATRC) Rating: 5
Start Price: $9.85
Points: +22.27
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: ATRICURE INC. (ATRC) Rating: 5
Start Price: $7.50
Points: +58.05
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: ATRICURE INC. (ATRC) Rating: 5
Start Price: $8.70
Points: +37.36
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: ATRICURE INC. (ATRC) Rating: 5
Start Price: $11.27
Points: +7.88
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: ATRICURE INC. (ATRC) Rating: 5
Start Price: $10.99
Points: +10.42
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
Porscheman 97.98 BUY Three to Six Months 01/12/2012 $11.22 $11.25
(-2.07%)
+0.27% +4.19% -3.92 view
onionman 57.42 BUY Six Months to a Year 01/01/2008 $9.85 $11.25
(-2.07%)
+14.21% -8.05% +22.27
Chadn 27.25 BUY Six Months to a Year 01/01/2008 $7.50 $11.25
(-2.07%)
+50.00% -8.05% +58.05
fishspinners 45.68 BUY Six Months to a Year 01/01/2008 $8.70 $11.25
(-2.07%)
+29.31% -8.05% +37.36
KEngh 95.01 BUY Six Months to a Year 01/01/2008 $11.27 $11.25
(-2.07%)
-0.18% -8.05% +7.88
Dskrove 90.37 BUY Six Months to a Year 01/01/2008 $10.99 $11.25
(-2.07%)
+2.37% -8.05% +10.42
Sponsored Links